Drug Type Mesenchymal stem cell therapy |
Synonyms Autologous HBadMSCs, HBadMSC |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Hope Biosciences LLCStartup |
Active Organization Hope Biosciences LLCStartup |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Injury, Chronic | Phase 2 | US | Hope Biosciences LLCStartup | 16 Apr 2024 |
Multiple Sclerosis | Phase 2 | US | - | 24 Nov 2021 |
Parkinson Disease | Phase 2 | US | Hope Biosciences LLCStartup | 28 Jun 2021 |
Stroke | Preclinical | US | Hope Biosciences LLCStartup | 04 Feb 2021 |
Huntington Disease | Preclinical | US | Hope Biosciences LLCStartup | 02 Feb 2021 |
Musculoskeletal Pain | Discovery | US | Hope Biosciences LLCStartup | 08 Feb 2021 |
Prostatic Cancer | Discovery | US | Hope Biosciences LLCStartup | 26 Jan 2021 |
Alzheimer Disease | Discovery | US | Hope Biosciences LLCStartup | 07 Dec 2019 |
Brain Injuries, Traumatic | Discovery | US | 29 Sep 2019 | |
Rheumatoid Arthritis | Discovery | US | Hope Biosciences LLCStartup | 25 Sep 2018 |
Phase 2 | 24 | Placebo+HB-adMSCs (HB-adMSCs) | bqvmcppdgb(fkfunqpqtf) = sklroslkdj cxuglbjape (gtmjzppory, rjfcrcfkdv - cfdrmmkdhb) View more | - | 20 May 2024 | ||
Placebo+HB-adMSCs (Placebo) | bqvmcppdgb(fkfunqpqtf) = egjzdbmdpb cxuglbjape (gtmjzppory, nnvdpsdowy - wkanzvgyua) View more | ||||||
Phase 2 | 51 | wnxrcctmkn(kvuivwacbj) = qmjduotdpr vjgctkvsby (fgpmjtanzp, kiqrenxtqh - nobwqlaqza) View more | - | 31 Oct 2023 | |||
Phase 1/2 | 15 | cxcvroddsb(ajhnnvgtrg) = vyusuooxgc fiikczurxn (fhsfqgugsa, zvjqhkgdbt - duejfvatby) View more | - | 22 Mar 2022 |